Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cells
- DOI
- 10.1016/j.ymthe.2025.08.017
- Published
- 2025-11
- Container
- Molecular Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymthe.2025.08.017,
title = {Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cells},
author = {Anastasia Kremer and Tatyana Ryaykenen and Xavier Segarra-Visent and Melanie Sauer and Leon Breuer and Yiying Wu and Qi Tang and David A. Cooper and Dimas Echeverria and Clothilde Philouze and Emilie Bayon and Dan Georgess and Reka A. Haraszti},
year = {2025},
journal = {Molecular Therapy},
doi = {10.1016/j.ymthe.2025.08.017},
url = {https://doi.org/10.1016/j.ymthe.2025.08.017}
}RIS
TY - JOUR TI - Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cells AU - Anastasia Kremer AU - Tatyana Ryaykenen AU - Xavier Segarra-Visent AU - Melanie Sauer AU - Leon Breuer AU - Yiying Wu AU - Qi Tang AU - David A. Cooper AU - Dimas Echeverria AU - Clothilde Philouze AU - Emilie Bayon AU - Dan Georgess AU - Reka A. Haraszti PY - 2025 JO - Molecular Therapy DO - 10.1016/j.ymthe.2025.08.017 UR - https://doi.org/10.1016/j.ymthe.2025.08.017 ER -
APA
Kremer, A., Ryaykenen, T., Segarra-Visent, X., Sauer, M., Breuer, L., Wu, Y., Tang, Q., Cooper, D. A., Echeverria, D., Philouze, C., Bayon, E., Georgess, D., & Haraszti, R. A. (2025). Optimized chemical structure extends silencing duration of therapeutic siRNAs in dividing cancer and immune cells. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.08.017
Source records
- crossref · retrieved 2026-09-26T12:19:01.656Z